{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:29:04Z","timestamp":1787765344592,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82070631"],"award-info":[{"award-number":["No.82070631"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Type 1 T helper (Th1) cells generate an efficient antitumor immune response in multiple malignancies. The functions of Th1 cells in malignant ascites (MA) have not been elucidated. The distribution of helper T cells in peritoneal fluid and peripheral blood was determined in patients and animal models with malignant ascites. The effects of Th1-derived interferon-\u03b3 (IFN-\u03b3) on the formation of malignant ascites were investigated. The mechanism underlying the recruitment of Th1 cells into peritoneal cavity was explored. In patients with malignant ascites and animal models of malignant ascites, the percentage of Th1 cells increased in peritoneal fluid compared with peripheral blood. Next, our experiment demonstrated that Th1 cells inhibited the growth of tumor cells by secreting IFN-\u03b3 in vitro. In murine models of malignant ascites, increased peritoneal fluid and shorter survival time were observed in IFN-\u03b3\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice compared with wild-type (WT) mice. Then, the levels of C-X-C motif chemokine ligand (CXCL) 9\/10 and the ratio of CXCR3\n                      <jats:sup>+<\/jats:sup>\n                      Th1 cells indicated the involvement of CXCL9, 10\/CXCR3 axis in the recruitment of Th1 cells into peritoneal cavity. As expected, in murine models of malignant ascites, the gradient between ascitic Th1 ratio and blood Th1 ratio decreased in CXCR3\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice compared with WT mice. IFN-\u03b3 secreted by recruited Th1 cells in peritoneal cavity inhibits the formation of malignant ascites. Hence, manipulation of Th1 cells or IFN-\u03b3 will provide a therapeutic candidate against malignant ascites.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41420-023-01312-5","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T09:02:59Z","timestamp":1674464579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interferon-\u03b3 secreted by recruited Th1 cells in peritoneal cavity inhibits the formation of malignant ascites"],"prefix":"10.1038","volume":"9","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanglong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4178-4916","authenticated-orcid":false,"given":"Yuhu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"1312_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/apt.15042","volume":"49","author":"L Du","year":"2019","unstructured":"Du L, Zhu S, Lu Z, Xu T, Bai T, Xu D, et al. Ascitic cholesterol is superior to serum-ascites albumin gradient in the detection of non-portal hypertensive ascites and the diagnosis of mixed ascites. Aliment Pharm Ther. 2019;49:91\u20138.","journal-title":"Aliment Pharm Ther"},{"key":"1312_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jgh.14768","volume":"35","author":"S Zhu","year":"2020","unstructured":"Zhu S, Du L, Xu D, Lu Z, Xu T, Li J, et al. Ascitic fluid total protein, a useful marker in non-portal hypertensive ascites. J Gastroenterol Hepatol. 2020;35:271\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"1312_CR3","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087\u2013107.","journal-title":"Hepatology"},{"key":"1312_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L.","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406\u201360.","journal-title":"J Hepatol"},{"key":"1312_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1665-2681(19)30865-8","volume":"13","author":"F Liu","year":"2014","unstructured":"Liu F, Kong X, Dou Q, Ye J, Xu D, Shang H, et al. Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites. Ann Hepatol. 2014;13:357\u201363.","journal-title":"Ann Hepatol"},{"key":"1312_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ejca.2005.11.018","volume":"42","author":"G Becker","year":"2006","unstructured":"Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer. 2006;42:589\u201397.","journal-title":"Eur J Cancer"},{"key":"1312_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","volume":"4","author":"SL Sangisetty","year":"2012","unstructured":"Sangisetty SL, Miner TJ. Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4:87\u201395.","journal-title":"World J Gastrointest Surg"},{"key":"1312_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1\u201310.","journal-title":"Immunity"},{"key":"1312_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/JLB.MR0318-097R","volume":"105","author":"D Chraa","year":"2019","unstructured":"Chraa D, Naim A, Olive D, Badou A. T lymphocyte subsets in cancer immunity: friends or foes. J Leukoc Biol. 2019;105:243\u201355.","journal-title":"J Leukoc Biol"},{"key":"1312_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s001090000180","volume":"78","author":"LJ Appleman","year":"2001","unstructured":"Appleman LJ, Tzachanis D, Grader-Beck T, van Puijenbroek AA, Boussiotis VA. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. J Mol Med. 2001;78:673\u201383.","journal-title":"J Mol Med"},{"key":"1312_CR11","doi-asserted-by":"publisher","first-page":"a030338","DOI":"10.1101\/cshperspect.a030338","volume":"10","author":"J Zhu","year":"2018","unstructured":"Zhu J. T helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb Perspect Biol. 2018;10:a030338.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1312_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/BF02986610","volume":"77","author":"H Shiku","year":"2003","unstructured":"Shiku H. Importance of CD4+ helper T-cells in antitumor immunity. Int J Hematol. 2003;77:435\u20138.","journal-title":"Int J Hematol"},{"key":"1312_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1164\/rccm.201310-1776OC","volume":"189","author":"H Lin","year":"2014","unstructured":"Lin H, Tong ZH, Xu QQ, Wu XZ, Wang XJ, Jin XG, et al. Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion. Am J Respir Crit Care Med. 2014;189:697\u2013706.","journal-title":"Am J Respir Crit Care Med"},{"key":"1312_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2020.12.016","volume":"500","author":"FS Yi","year":"2021","unstructured":"Yi FS, Zhai K, Shi HZ. Helper T cells in malignant pleural effusion. Cancer Lett. 2021;500:21\u201328.","journal-title":"Cancer Lett"},{"key":"1312_CR15","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/eji.202048574","volume":"50","author":"K Zhai","year":"2020","unstructured":"Zhai K, Shi XY, Yi FS, Huang ZY, Wu XZ, Dong SF, et al. IL-10 promotes malignant pleural effusion by regulating T(H) 1 response via an miR-7116-5p\/GPR55\/ERK pathway in mice. Eur J Immunol. 2020;50:1798\u2013809.","journal-title":"Eur J Immunol"},{"key":"1312_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","volume":"222","author":"R Kennedy","year":"2008","unstructured":"Kennedy R, Celis E. Multiple roles for CD4+ T cells in anti-tumor immune responses. Immunol Rev. 2008;222:129\u201344.","journal-title":"Immunol Rev"},{"key":"1312_CR17","doi-asserted-by":"publisher","first-page":"a028480","DOI":"10.1101\/cshperspect.a028480","volume":"11","author":"E Alspach","year":"2019","unstructured":"Alspach E, Lussier DM, Schreiber RD. Interferon gamma and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity. Cold Spring Harb Perspect Biol. 2019;11:a028480.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1312_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2567.2010.03289.x","volume":"130","author":"YY Wan","year":"2010","unstructured":"Wan YY. Multi-tasking of helper T cells. Immunology. 2010;130:166\u201371.","journal-title":"Immunology"},{"key":"1312_CR19","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","volume":"17","author":"MR Zaidi","year":"2011","unstructured":"Zaidi MR, Merlino G. The two faces of interferon-gamma in cancer. Clin Cancer Res. 2011;17:6118\u201324.","journal-title":"Clin Cancer Res"},{"key":"1312_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2741\/3261","volume":"14","author":"R Bonecchi","year":"2009","unstructured":"Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci (Landmark Ed). 2009;14:540\u201351.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1312_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2009.07.011","volume":"34","author":"YH Oo","year":"2010","unstructured":"Oo YH, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun. 2010;34:45\u201354.","journal-title":"J Autoimmun"},{"key":"1312_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S1499-3872(14)60305-2","volume":"13","author":"HM Xu","year":"2014","unstructured":"Xu HM. Th1 cytokine-based immunotherapy for cancer. Hepatobiliary Pancreat Dis Int. 2014;13:482\u201394.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1312_CR23","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1378\/chest.128.6.4030","volume":"128","author":"M Okamoto","year":"2005","unstructured":"Okamoto M, Hasegawa Y, Hara T, Hashimoto N, Imaizumi K, Shimokata K, et al. T-helper type 1\/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest. 2005;128:4030\u20135.","journal-title":"Chest"},{"key":"1312_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11596-013-1066-2","volume":"33","author":"WB Yang","year":"2013","unstructured":"Yang WB, Ye ZJ, Xiang F, Zhang JC, Zhou Q. Th17\/Treg imbalance in malignant pleural effusion. J Huazhong Univ Sci Technol Med Sci. 2013;33:27\u201332.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"1312_CR25","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1164\/rccm.201207-1307OC","volume":"186","author":"ZJ Ye","year":"2012","unstructured":"Ye ZJ, Zhou Q, Yin W, Yuan ML, Yang WB, Xiong XZ, et al. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion. Am J Respir Crit Care Med. 2012;186:1168\u201379.","journal-title":"Am J Respir Crit Care Med"},{"key":"1312_CR26","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1158\/1078-0432.CCR-08-2641","volume":"15","author":"XJ Qin","year":"2009","unstructured":"Qin XJ, Shi HZ, Deng JM, Liang QL, Jiang J, Ye ZJ. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res. 2009;15:2231\u20137.","journal-title":"Clin Cancer Res"},{"key":"1312_CR27","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1164\/rccm.200504-588OC","volume":"172","author":"YQ Chen","year":"2005","unstructured":"Chen YQ, Shi HZ, Qin XJ, Mo WN, Liang XD, Huang ZX, et al. CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med. 2005;172:1434\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1312_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1465-9921-12-77","volume":"12","author":"ZJ Ye","year":"2011","unstructured":"Ye ZJ, Zhou Q, Zhang JC, Li X, Wu C, Qin SM, et al. CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism. Respir Res. 2011;12:77.","journal-title":"Respir Res"},{"key":"1312_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/84209","volume":"2","author":"C Gerard","year":"2001","unstructured":"Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2:108\u201315.","journal-title":"Nat Immunol"},{"key":"1312_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/JLB.5MR0320-205R","volume":"108","author":"E Russo","year":"2020","unstructured":"Russo E, Santoni A, Bernardini G. Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer. J Leukoc Biol. 2020;108:673\u201385.","journal-title":"J Leukoc Biol"},{"key":"1312_CR31","first-page":"287","volume":"1836","author":"C Billottet","year":"2013","unstructured":"Billottet C, Quemener C, Bikfalvi A. CXCR3, a double-edged sword in tumor progression and angiogenesis. Biochim Biophys Acta. 2013;1836:287\u201395.","journal-title":"Biochim Biophys Acta"},{"key":"1312_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.etp.2010.06.007","volume":"64","author":"R Badraoui","year":"2012","unstructured":"Badraoui R, Rebai T. Effect of malignant ascites on antioxidative potency of two tumoral cells-induced bone metastases: Walker 256\/B and MatLyLu. Exp Toxicol Pathol. 2012;64:65\u201368.","journal-title":"Exp Toxicol Pathol"},{"key":"1312_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jpba.2019.03.054","volume":"170","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Lou JW, Zhang Q, Li ZL, Bao BH, Cao YD, et al. Determination of kansuiphorin C and kansuinin A in rat feces using UFLC-MS\/MS and its application in the comparative excretion study on normal and malignant ascites rats. J Pharm Biomed Anal. 2019;170:254\u201363.","journal-title":"J Pharm Biomed Anal"},{"key":"1312_CR34","doi-asserted-by":"publisher","first-page":"108979","DOI":"10.1016\/j.biopha.2019.108979","volume":"115","author":"Z Deng","year":"2019","unstructured":"Deng Z, Gao S, Xiao X, Yin N, Ma S, Li W, et al. The effect of earthworm extract on mice S180 tumor growth and apoptosis. Biomed Pharmacother. 2019;115:108979.","journal-title":"Biomed Pharmacother"},{"key":"1312_CR35","doi-asserted-by":"crossref","unstructured":"Yu J, Ji HY, Liu C, Liu AJ. The structural characteristics of an acid-soluble polysaccharide from Grifola frondosa and its antitumor effects on H22-bearing mice. Int J Biol Macromol. 2020;S0141\u20138130(20)33200\u20131.","DOI":"10.1016\/j.ijbiomac.2020.05.054"},{"key":"1312_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2007.10.023","volume":"260","author":"J Zhang","year":"2008","unstructured":"Zhang J, Wang X, Lu H. Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase. Cancer Lett. 2008;260:127\u201336.","journal-title":"Cancer Lett"},{"key":"1312_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0456-6","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen Y, Meng L, Shang H, Dou Q, Lu Z, Liu L, et al. beta2 spectrin-mediated differentiation repressed the properties of liver cancer stem cells through beta-catenin. Cell Death Dis. 2018;9:424.","journal-title":"Cell Death Dis"},{"key":"1312_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep08705","volume":"5","author":"X He","year":"2015","unstructured":"He X, Liu F, Yan J, Zhang Y, Yan J, Shang H, et al. Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo. Sci Rep. 2015;5:8705.","journal-title":"Sci Rep."},{"key":"1312_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2372-9","volume":"11","author":"T Xu","year":"2020","unstructured":"Xu T, Lu Z, Xiao Z, Liu F, Chen Y, Wang Z, et al. Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin-avbeta6 integrin in liver fibrosis. Cell Death Dis. 2020;11:199.","journal-title":"Cell Death Dis"},{"key":"1312_CR40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/j.1478-3231.2012.02812.x","volume":"32","author":"Z Wang","year":"2012","unstructured":"Wang Z, Song Y, Tu W, He X, Lin J, Liu F. beta-2 spectrin is involved in hepatocyte proliferation through the interaction of TGFbeta\/Smad and PI3K\/AKT signalling. Liver Int. 2012;32:1103\u201311.","journal-title":"Liver Int"},{"key":"1312_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1582-4934.2011.01290.x","volume":"16","author":"Z Wang","year":"2012","unstructured":"Wang Z, Liu F, Tu W, Chang Y, Yao J, Wu W, et al. Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis. J Cell Mol Med. 2012;16:118\u201328.","journal-title":"J Cell Mol Med"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01312-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T09:04:18Z","timestamp":1674464658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1312"],"URL":"https:\/\/doi.org\/10.1038\/s41420-023-01312-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2049525\/v1","asserted-by":"object"}]},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"19 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All contributing authors agreed to the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mice and human samples were handled under the recommendations of the Ethics Committee of Tongji Medical School (ChiCTR\u2010BOC\u201017011724 (\n                      \n                      )).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"25"}}